Meng‐Yu Weng

523 total citations
11 papers, 250 citations indexed

About

Meng‐Yu Weng is a scholar working on Epidemiology, Rheumatology and Surgery. According to data from OpenAlex, Meng‐Yu Weng has authored 11 papers receiving a total of 250 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Epidemiology, 4 papers in Rheumatology and 3 papers in Surgery. Recurrent topics in Meng‐Yu Weng's work include Salivary Gland Disorders and Functions (3 papers), Salivary Gland Tumors Diagnosis and Treatment (3 papers) and Eosinophilic Disorders and Syndromes (2 papers). Meng‐Yu Weng is often cited by papers focused on Salivary Gland Disorders and Functions (3 papers), Salivary Gland Tumors Diagnosis and Treatment (3 papers) and Eosinophilic Disorders and Syndromes (2 papers). Meng‐Yu Weng collaborates with scholars based in Taiwan, United States and Australia. Meng‐Yu Weng's co-authors include Yu‐Tung Huang, Tsung‐Hsueh Lu, Ming-Fei Liu, Yea‐Huei Kao Yang, Edward Chia‐Cheng Lai, Pi‐Ling Chou, Chih-Chiang Shen, Chi‐Kuang Sun, Jinn‐Kong Sheu and Po‐Yu Lin and has published in prestigious journals such as Annals of the Rheumatic Diseases, The Journal of Physical Chemistry Letters and BioMed Research International.

In The Last Decade

Meng‐Yu Weng

10 papers receiving 247 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meng‐Yu Weng Taiwan 8 120 74 68 51 36 11 250
Ioanna Tatouli Greece 4 123 1.0× 47 0.6× 106 1.6× 22 0.4× 49 1.4× 5 251
Kenjiro Shima Japan 13 91 0.8× 122 1.6× 21 0.3× 112 2.2× 21 0.6× 29 453
Pranav K. Vyas United States 8 215 1.8× 68 0.9× 28 0.4× 71 1.4× 15 0.4× 16 374
Guido Morcaldi Italy 8 47 0.4× 54 0.7× 19 0.3× 18 0.4× 37 1.0× 13 276
Viorel Biciuşcă Romania 10 21 0.2× 41 0.6× 61 0.9× 66 1.3× 11 0.3× 39 295
Hacı Ahmet Demir Türkiye 11 128 1.1× 92 1.2× 24 0.4× 34 0.7× 15 0.4× 36 341
F. Pasquet France 7 25 0.2× 56 0.8× 14 0.2× 52 1.0× 15 0.4× 30 293
Virgilia Soto‐Abraham Mexico 7 45 0.4× 30 0.4× 43 0.6× 9 0.2× 22 0.6× 27 166
Yusuke Ushio Japan 9 23 0.2× 38 0.5× 40 0.6× 46 0.9× 81 2.3× 48 242
Rolando Cimaz Italy 11 37 0.3× 41 0.6× 227 3.3× 49 1.0× 28 0.8× 19 363

Countries citing papers authored by Meng‐Yu Weng

Since Specialization
Citations

This map shows the geographic impact of Meng‐Yu Weng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meng‐Yu Weng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meng‐Yu Weng more than expected).

Fields of papers citing papers by Meng‐Yu Weng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meng‐Yu Weng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meng‐Yu Weng. The network helps show where Meng‐Yu Weng may publish in the future.

Co-authorship network of co-authors of Meng‐Yu Weng

This figure shows the co-authorship network connecting the top 25 collaborators of Meng‐Yu Weng. A scholar is included among the top collaborators of Meng‐Yu Weng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meng‐Yu Weng. Meng‐Yu Weng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Chuang, Anthony, Daniel Hsiang‐Te Tsai, Meng‐Yu Weng, Huei‐Kai Huang, & Edward Chia‐Cheng Lai. (2025). Effectiveness of JAK inhibitors in biologics-naïve patients with RA: a population-based study. Lara D. Veeken. 64(8). 4668–4677. 1 indexed citations
2.
3.
Lee, Nan–Yao, et al.. (2024). Increased risk of Pneumocystis jirovecii colonization in rheumatoid arthritis patients on biologics and Janus kinase inhibitor. Journal of Microbiology Immunology and Infection. 58(1). 112–119. 1 indexed citations
4.
Huang, Yu‐Tung, Tsung‐Hsueh Lu, Pi‐Ling Chou, & Meng‐Yu Weng. (2021). Diagnostic Delay in Patients with Primary Sjögren’s Syndrome: A Population-Based Cohort Study in Taiwan. Healthcare. 9(3). 363–363. 14 indexed citations
5.
Huang, Hung‐Ling, et al.. (2020). The significance of myositis autoantibodies in idiopathic inflammatory myopathy concomitant with interstitial lung disease. Neurological Sciences. 42(7). 2855–2864. 11 indexed citations
6.
Weng, Meng‐Yu, Edward Chia‐Cheng Lai, & Yea‐Huei Kao Yang. (2019). Increased risk of coronary heart disease among patients with idiopathic inflammatory myositis: a nationwide population study in Taiwan. Lara D. Veeken. 58(11). 1935–1941. 17 indexed citations
7.
Shen, Chih-Chiang, et al.. (2017). In Situ Monitoring of Chemical Reactions at a Solid–Water Interface by Femtosecond Acoustics. The Journal of Physical Chemistry Letters. 8(21). 5430–5437. 13 indexed citations
8.
Weng, Meng‐Yu, Nan–Yao Lee, Wei‐Chieh Lin, et al.. (2013). Pneumocystis jirovecii Pneumonia in Systemic Lupus Erythematosus From Southern Taiwan. JCR Journal of Clinical Rheumatology. 19(5). 252–258. 28 indexed citations
9.
Weng, Meng‐Yu, Yu‐Tung Huang, Ming-Fei Liu, & Tsung‐Hsueh Lu. (2011). Incidence and Mortality of Treated Primary Sjögren’s Syndrome in Taiwan: A Population-based Study. The Journal of Rheumatology. 38(4). 706–708. 61 indexed citations
10.
Weng, Meng‐Yu, Yu‐Tung Huang, Ming-Fei Liu, & Tsung‐Hsueh Lu. (2011). Incidence of cancer in a nationwide population cohort of 7852 patients with primary Sjögren's syndrome in Taiwan. Annals of the Rheumatic Diseases. 71(4). 524–527. 80 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ioanna Tatouli Breakdown of academic impact, for papers by Kenjiro Shima Breakdown of academic impact, for papers by Pranav K. Vyas Breakdown of academic impact, for papers by Guido Morcaldi Breakdown of academic impact, for papers by Viorel Biciuşcă Breakdown of academic impact, for papers by Hacı Ahmet Demir Breakdown of academic impact, for papers by F. Pasquet Breakdown of academic impact, for papers by Virgilia Soto‐Abraham Breakdown of academic impact, for papers by Yusuke Ushio Breakdown of academic impact, for papers by Rolando Cimaz
Rankless by CCL
2026